Cargando…

Transparency of Results Reporting in Cancer Clinical Trials

This cross-sectional study investigates rates of results reporting among oncology clinical trials across trial registries, medical journals, and medical conferences.

Detalles Bibliográficos
Autores principales:	Kao, Jennifer, Ross, Joseph S., Miller, Jennifer E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413165/ https://www.ncbi.nlm.nih.gov/pubmed/37556143 http://dx.doi.org/10.1001/jamanetworkopen.2023.28117

Ejemplares similares

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
por: Miller, Jennifer E, et al.
Publicado: (2017)

Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials
por: Ramachandran, Reshma, et al.
Publicado: (2021)

Transparency in recruiting patients for clinical trials
por: Joshi, Veena
Publicado: (2013)

Improving information transparency between dermatology residency programs and trainees: Report from the Association of Professors of Dermatology Work Group on Transparency
por: Jia, Justin L., et al.
Publicado: (2021)

Does information from ClinicalTrials.gov increase transparency and reduce bias? Results from a five-report case series
por: Adam, Gaelen P., et al.
Publicado: (2018)

Transparency and Accountability of Medicaid Section 1115 Waiver Demonstration Programs Under the Affordable Care Act
por: Lopez, Leo, et al.
Publicado: (2020)

Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
por: Miller, Jennifer, et al.
Publicado: (2019)

Transparent peer review trial: the results
por: Cosgrove, Andrew, et al.
Publicado: (2018)

Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database
por: Huang, Ren-Qian, et al.
Publicado: (2023)

Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
por: Roberto, Anna, et al.
Publicado: (2018)

Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
por: Axson, Sydney A, et al.
Publicado: (2021)

Public disclosure of clinical trial results at Clinical Trial Registry of India- Need for transparency in research!
por: Munshi, Renuka, et al.
Publicado: (2023)

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
por: Zou, Constance X., et al.
Publicado: (2018)

The authors reply regarding transparency, balance and perspective on intervention at full dilation
por: Muraca, Giulia M., et al.
Publicado: (2022)

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
por: Miller, Jennifer E, et al.
Publicado: (2015)

Transparent reporting of adaptive clinical trials using concurrently randomised cohorts
por: Marschner, Ian C, et al.
Publicado: (2023)

Transparent reporting of research results in eLife
por: Teare, M Dawn
Publicado: (2016)

Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
por: Pellat, Anna, et al.
Publicado: (2022)

Principles of transparency and clinical trial registration
por: Yim, Dong-Seok
Publicado: (2017)

Transparency Needed for Economic Analyses of PA Programs
por: Holdford, David
Publicado: (2003)

Transparency of Outcome Reporting and Trial Registration of Randomized Controlled Trials Published in the Journal of Consulting and Clinical Psychology
por: Azar, Marleine, et al.
Publicado: (2015)

Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials
por: Sedrak, Mina S., et al.
Publicado: (2020)

Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
por: Jain, Neelesh P, et al.
Publicado: (2023)

Reporting bias in clinical trials: Progress toward transparency and next steps
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

The Necessities for the Transparent Peer-Review
por: Lee, Jung Hun, et al.
Publicado: (2021)

Health Canada: optimizing transparency and its impact for patients
por: Abi-Jaoude, Elia, et al.
Publicado: (2021)

Reply: Non-transparent and insufficient descriptions of non-validated microbiome methods and related reproductive outcome results should be interpreted with caution
por: Koedooder, R, et al.
Publicado: (2019)

Transparent Peer Review of Grant Applications
por: Lee, Jung Hun, et al.
Publicado: (2021)

Transparency, Accessibility, and Variability of US Hospital Price Data
por: Haque, Waqas, et al.
Publicado: (2021)

Addressing concerns regarding associated costs, transparency, and integrity of research in recent stem cell trial
por: Riordan, Neil H., et al.
Publicado: (2021)

Transparency and reporting characteristics of COVID-19 randomized controlled trials
por: Kapp, Philipp, et al.
Publicado: (2022)

Transparency and Variability in Pricing for Pediatric Outpatient Imaging in US Children’s Hospitals
por: Hayatghaibi, Shireen E., et al.
Publicado: (2022)

Registration of clinical trials in anesthesiology: promoting transparency in clinical research
por: Schmidt, André P., et al.
Publicado: (2022)

Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States
por: Lassman, Scott M, et al.
Publicado: (2017)

COVID-19 and medical education in Japan: a struggle for fairness and transparency
por: Kaneda, Yudai, et al.
Publicado: (2023)

Do Non-Ionic Contrast Media Temporarily Improve Corneal Transparency?
por: Tatham, Andrew J., et al.
Publicado: (2013)

Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
por: Baronikova, Slavka, et al.
Publicado: (2019)

Lack of transparency in clinical trials: a call for action
por: Ramírez, Jorge H
Publicado: (2013)

Blockchain protocols in clinical trials: Transparency and traceability of consent
por: Benchoufi, Mehdi, et al.
Publicado: (2018)

Transparency or Proper Study Valuation Procedures Missed?
por: Favato, Giampiero, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ufqbjtgbdbeih9662pcleif93p